KRAB-ZFPs have been shown to suppress the growth of many tumors through Wnt/β-catenin and AKT signaling, including esophageal squamous cell carcinoma, colorectal cancer, and breast cancer [21, 33, 43]. This evidence concerns the gene AKT1 and breast cancer.